Advancing Neuromuscular Research Through Collaboration and Patient-Centered Perspectives: Łukasz Sznajder, PhD, MSc

WATCH TIME: 2 minutes | Captions are auto-generated and may contain errors.

"I really think that modern science requires collaboration across disciplines. The interdisciplinary nature of today's research requires that there is no impactful research being done today by one lab, typically; it requires a combination of experts from multiple fields."

In February 2026, the Muscular Dystrophy Association (MDA) announced that Łukasz Sznajder, PhD, MSc, assistant professor in the Department of Chemistry and Biochemistry at the University of Nevada, Las Vegas, was named the first recipient of the MDA Research Momentum Award. This award recognizes early-career investigators whose research demonstrated innovation and potential to influence the future of neuromuscular disease science. The honor was presented at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, held March 9-11, in Orlando, Florida, a meeting that convened the global neuromuscular community to share research advancements and encourage collaboration.¹

The MDA Research Momentum Award was designed to highlight investigators in 5 years of their first faculty appointment who demonstrated scientific originality, leadership potential, and engagement within the research community. Sznajder was recognized for his work in molecular genetics focused on mechanisms underlying neuromuscular and neuropsychiatric disorders, including myotonic dystrophy and amyotrophic lateral sclerosis, with the aim of informing targeted therapeutic strategies. His contributions also reflected ongoing collaboration, mentorship, and participation in MDA-supported initiatives, alongside a body of research spanning nearly 2 decades with multiple peer-reviewed publications and sustained funding.

At the 2026 MDA Conference, Sznajder sat down with NeurologyLive^® to discuss the professional validation of his research journey, emphasizing the risks he took in pursuing uncertain projects that have since gained recognition. He expressed a long-term vision of eradicating neuromuscular disorders, drawing parallels to the historical elimination of polio and the retirement of iron lungs. He underscored that modern scientific progress depends heavily on interdisciplinary collaboration. Additionally, he highlighted patient involvement as a critical component, noting that research must remain relevant to patients’ lived experiences and that their perspectives should inform decision-making in therapeutic development.

Click here for more MDA 2026 coverage.

REFERENCES
1. Muscular Dystrophy Association Announces Łukasz Sznajder, PhD, MSc, to Receive Inaugural MDA Research Momentum Award. Muscular Dystrophy Association. February 17, 2026. Accessed April 23, 2026. https://www.mda.org/press-releases/2026/muscular-dystrophy-association-announces-lukasz-sznajder-phd-msc-to-receive-inaugural-mda-research